Relay Therapeutics Inc (RLAY) — Financial Flexibility Index
Relay Therapeutics Inc (RLAY) has a Financial Flexibility Index of -0.89x as of March 2026. Free cash flow of $-51.11 Million (operating CF $-51.11 Million minus capex $0.00) represents -1% of total liabilities ($57.43 Million). Check Relay Therapeutics Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Relay Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Relay Therapeutics Inc across 8 annual periods. See RLAY working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Relay Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Relay Therapeutics Inc. For the full company profile including market capitalisation, see Relay Therapeutics Inc (RLAY) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.33x | $-235.04 Million | $-235.46 Million | $54.27 Million | ▼ -63.9% |
| 2024 | -2.64x | $-247.09 Million | $-249.11 Million | $93.50 Million | ▲ +17.9% |
| 2023 | -3.22x | $-296.19 Million | $-300.32 Million | $91.98 Million | ▼ -118.5% |
| 2022 | -1.47x | $-220.43 Million | $-229.49 Million | $149.55 Million | ▼ -129.9% |
| 2021 | -0.64x | $-70.94 Million | $-74.41 Million | $110.64 Million | ▲ +76.7% |
| 2020 | -2.75x | $-100.56 Million | $-102.49 Million | $36.54 Million | ▼ -2615.3% |
| 2019 | -0.10x | $-58.13 Million | $-66.13 Million | $573.51 Million | ▼ -28.8% |
| 2018 | -0.08x | $-42.45 Million | $-44.13 Million | $539.54 Million | — |